One-stage direct-to-implant breast reconstruction using acellular dermal matrix

Affiliations

¹ Addenbrooke's Hospital, Cambridge, UK; University of Cambridge, Cambridge, UK; School of Medicine, Anglia Ruskin University, Cambridge, UK. Electronic address: john.benson@addenbrookes.nhs.uk.

Comment

John R Benson. Lancet Oncol. 2018 Sep.

. 2018 Sep;19(9):1141-1143.

doi: 10.1016/S1470-2045(18)30424-8. Epub 2018 Aug 10.

¹ Addenbrooke's Hospital, Cambridge, UK; University of Cambridge, Cambridge, UK; School of Medicine, Anglia Ruskin University, Cambridge, UK. Electronic address: john.benson@addenbrookes.nhs.uk.

No abstract available

Comment on

Quality of life and patient satisfaction after one-stage implant-based breast reconstruction with an acellular dermal matrix versus two-stage breast reconstruction (BRIOS): primary outcome of a randomised, controlled trial.
Negenborn VL, Young-Afat DA, Dikmans REG, Smit JM, Winters HAH, Don Griot JPW, Twisk JWR, Ruhé PQ, Mureau MAM, Lapid O, Moerman E, van Turnhout AAWM, Ritt MJPF, Bouman MB, Mullender MG. Negenborn VL, et al. Lancet Oncol. 2018 Sep;19(9):1205-1214. doi: 10.1016/S1470-2045(18)30378-4. Epub 2018 Aug 10. Lancet Oncol. 2018. PMID: 30104147 Clinical Trial.